These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20554018)

  • 21. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
    Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
    J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice.
    Zavros Y; Rieder G; Ferguson A; Samuelson LC; Merchant JL
    Gastroenterology; 2002 Jan; 122(1):119-33. PubMed ID: 11781287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO; Hatlebakk JG; Castell DO
    Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
    Abed MN; Alassaf FA; Jasim MHM; Alfahad M; Qazzaz ME
    Pharmacology; 2020; 105(11-12):645-651. PubMed ID: 32289807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divalent cations regulate acidity within the lumen and tubulovesicle compartment of gastric parietal cells.
    Gerbino A; Hofer AM; McKay B; Lau BW; Soybel DI
    Gastroenterology; 2004 Jan; 126(1):182-95. PubMed ID: 14699499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid buffering effects of aqueous leaf extract of Ocimum gratissimum L. in the rabbit stomach.
    Nwangwu S; Ajeigbe K; Omotoso D; Josiah S; Olayanju A; Bolaji A
    Turk J Gastroenterol; 2013; 24(3):204-10. PubMed ID: 24226712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of omeprazole on ethanol lesions.
    Abdel Fattaha NA; Abdel-Rahman MS
    Toxicol Lett; 2000 Dec; 118(1-2):21-30. PubMed ID: 11137305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Sep; 51(3):421-31. PubMed ID: 11016862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach.
    Stolte M; Meining A; Seifert E; Alexandridis T
    Pathol Res Pract; 2000; 196(1):9-13. PubMed ID: 10674267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of omeprazole on the gastric mucosa.
    Driman DK; Tougas G; Riddell R
    Gastroenterology; 2000 Oct; 119(4):1176. PubMed ID: 11203030
    [No Abstract]   [Full Text] [Related]  

  • 32. Gastroprotective properties of Myristica malabarica against indometacin-induced stomach ulceration: a mechanistic exploration.
    Banerjee D; Maity B; Bauri AK; Bandyopadhyay SK; Chattopadhyay S
    J Pharm Pharmacol; 2007 Nov; 59(11):1555-65. PubMed ID: 17976268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
    Morozov IA
    Eksp Klin Gastroenterol; 2002; (3):94-100, 122. PubMed ID: 12353402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of rabeprazole on parietal cells and enterochromaffin-like cells in rats: a comparison with omeprazole.
    Tari A; Kawano M; Kodama K; Yonei Y; Okahara S; Haruma K; Sumii K; Kajiyama G
    J Gastroenterol; 2002; 37(3):177-85. PubMed ID: 11931530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
    Kim JM; Choi SM; Kim DH; Oh TY; Ahn BO; Kwon JW; Kim WB
    Arzneimittelforschung; 2005; 55(7):387-93. PubMed ID: 16080278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase.
    Beil W; Sewing KF; Busche R; Wagner S
    Gut; 2001 Feb; 48(2):157-62. PubMed ID: 11156634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corpus-active gastritis with focal atrophy and parietal cell hyperplasia related to long-term use of omeprazole.
    Declich P; Ambrosiani L; Bellone S; Tavani E
    Virchows Arch; 1999 Aug; 435(2):151-2. PubMed ID: 10599315
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of omeprazole on ultrastructural changes in gastric parietal cells.
    Karasawa H; Tani N; Miwa T
    Gastroenterol Jpn; 1988 Feb; 23(1):1-8. PubMed ID: 3350276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.